Your World, Fully Explored.
Published loading...Updated

AAVantgarde Bio Presents Positive Data for Retinitis Pigmentosa and Stargardt Disease Therapies

Summary by ophthalmologytimes.com
AAVantgarde Bio reveals promising safety and efficacy data for AAV-based therapies targeting Usher syndrome and Stargardt disease at ARVO 2025.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

modernretina.com broke the news in on Tuesday, May 13, 2025.
Sources are mostly out of (0)

Similar News Topics